CVPBF(CVPBF)
CVPBF
No analyst ratings available
No analyst price targets available for CVPBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.03T | $1.08T | $1.12T | $1.15T |
| Low | $1.01T | $1.05T | $1.10T | $1.13T |
| High | $1.08T | $1.11T | $1.16T | $1.19T |
| EBITDA Avg | $83.64B | $87.16B | $91.06B | $93.23B |
| Low | $81.89B | $85.20B | $89.08B | $91.20B |
| High | $87.12B | $89.80B | $94.32B | $96.56B |
| EBIT Avg | $43.98B | $45.82B | $47.87B | $49.01B |
| Low | $43.05B | $44.79B | $46.83B | $47.94B |
| High | $45.80B | $47.21B | $49.59B | $50.77B |
| Net Income Avg | $30.65B | $33.33B | $36.42B | $38.24B |
| Low | $29.78B | $32.39B | $35.38B | $37.16B |
| High | $32.07B | $34.89B | $38.11B | $40.02B |
| EPS Avg | $3.42 | $3.72 | $4.07 | $4.27 |
| Low | $3.33 | $3.62 | $3.95 | $4.15 |
| High | $3.58 | $3.90 | $4.26 | $4.47 |
| Analysts (Rev / EPS) | 19 / 1 | 20 / 1 | 10 / 1 | 11 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $257.23B | $257.14B | $260.71B |
| Low | $257.23B | $257.14B | $260.71B |
| High | $257.23B | $257.14B | $260.71B |
| EBITDA Avg | $20.83B | $20.82B | $21.11B |
| Low | $20.83B | $20.82B | $21.11B |
| High | $20.83B | $20.82B | $21.11B |
| EBIT Avg | $10.95B | $10.95B | $11.10B |
| Low | $10.95B | $10.95B | $11.10B |
| High | $10.95B | $10.95B | $11.10B |
| Net Income Avg | $7.47B | $7.37B | $9.02B |
| Low | $7.47B | $7.37B | $9.02B |
| High | $7.47B | $7.37B | $9.02B |
| EPS Avg | $0.84 | $0.83 | $1.01 |
| Low | $0.84 | $0.83 | $1.01 |
| High | $0.84 | $0.83 | $1.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |